cabazitaxel

Explore academic connections and research related to this keyword

166
Views
7
Total Connections

Related Articles & Bibliographies

1
Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study.
Sarantopoulos, John;Mita, Alain C;He, Aiwu;Wade, James L;Hsueh, Chung-Tsen;Morris, John C;Lockhart,...
2017 cancer chemotherapy and pharmacology DOI: 10.1007/s00280-016-3... 213 views
2
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Neal, Joel W;Dahlberg, Suzanne E;Wakelee, Heather A;Aisner, Seena C;Bowden, Michaela;Huang, Ying;Car...
2016 the lancet oncology DOI: S1470-2045(16)30561-... 248 views
3
Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.
Qian, Zhi Rong;Li, Tingting;Ter-Minassian, Monica;Yang, Juhong;Chan, Jennifer A;Brais, Lauren K;Masu...
2016 pancreas 294 views
4
critical appraisal of cabazitaxel in the management of advanced prostate cancer
;Sumanta Kumar Pal;Przemyslaw Twardowski;Oliver Sartor
2010 imaging science journal 126 views

Related Journals

cancer chemotherapy and pharmacology
ISSN: 1432-0843 373 views
the lancet oncology
ISSN: 1474-5488 383 views
pancreas
ISSN: 1536-4828 370 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.